Results of Phase III POLLUX trial on daratumumab in multiple myeloma
Perspectives on future paths to cure multiple myeloma
The aims of the Genomics England CLL pilot
Transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (CLL)?
The use of CLL-IPI, a new prognostic index for CLL